|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||12.27 - 12.27|
|52-week range||12.27 - 12.27|
|Beta (5Y monthly)||1.71|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Adverum Biotechnologies (ADVM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Investors need to pay close attention to Adverum Biotechnologies (ADVM) stock based on the movements in the options market lately.
Just because a business does not make any money, does not mean that the stock will go down. For example, although...